EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)

S J Ryan Arends iD, Deborah Butler, Nicole Scangarella-Oman iD, Mariana Castanheira iD, Rodrigo E Mendes iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01525-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von S J Ryan Arends und 4 weiteren Autor:innen. Beteiligte Einrichtung: JMI Laboratories, North Liberty, Iowa, USA. Hauptthemen laut MEDLINE: Urinary Tract Infections, Escherichia coli Infections. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The in vitro activities of gepotidacin and comparator agents against 3,560 Escherichia coli and 344 Staphylococcus saprophyticus collected from female (81.1%) and male (18.9%) patients with urinary tract infections (UTIs) in a global prospective surveillance program in 2019 to 2020 were determined. Isolates collected from 92 medical centers in 25 countries, including the United States, Europe, Latin America, and Japan, were tested for susceptibility by reference methods in a central monitoring laboratory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsEscherichia coli InfectionsMaleFemaleUnited StatesHumansEscherichia coliStaphylococcus saprophyticusTrimethoprim, Sulfamethoxazole Drug CombinationProspective StudiesAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-LactamasesAcenaphthenesHeterocyclic Compounds, 3-Ring

Stichwörter der Autor:innen

ESBLoralresistanceurinary tract infection

Substanzen

Trimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial Agentsbeta-LactamasesgepotidacinAcenaphthenesHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • JMI Laboratories, North Liberty, Iowa, USA.

ORCID-Profile: S J Ryan Arends, Nicole Scangarella-Oman, Mariana Castanheira, Rodrigo E Mendes

Förderung

  • GlaxoSmithKline

Zitieren

APA

Arends, S. J. R., Butler, D., Scangarella-Oman, N., Castanheira, M., & Mendes, R. E. (2023). Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020). Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01525-22

Vancouver

Arends SJR, Butler D, Scangarella-Oman N, Castanheira M, Mendes RE. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020). Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01525-22

BibTeX
@article{Arends2023,
  author = {Arends, S J Ryan and Butler, Deborah and Scangarella-Oman, Nicole and Castanheira, Mariana and Mendes, Rodrigo E},
  title = {Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01525-22}
}
Kostenlos starten →